|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.372 SEK | +0.54% |
|
-3.88% | -14.87% |
| Apr. 18 | Swedish Diagnostics Company AroCell Secures US Patent | MT |
| Feb. 22 | AroCell AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
AroCell AB (publ) reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 9.51 million compared to SEK 12.47 million a year ago. Net loss was SEK 17.14 million compared to SEK 16.52 million a year ago.
Basic loss per share from continuing operations was SEK 0.07 compared to SEK 0.07 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -14.87% | 7.82M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
AROCELL AB 
